The dysregulation of RBPs, including HuR, PTB, and YTHDF1, is linked to metabolic diseases such as obesity, diabetes, and non-alcoholic fatty liver disease. Here, YTHDF1 is linked to metabolic dysfunction-associated steatotic liver disease.